古汉医药
(000590)
| 流通市值：19.15亿 | | | 总市值：19.16亿 |
| 流通股本：2.39亿 | | | 总股本：2.39亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 134,174,808.98 | 71,667,915.65 | 337,673,206.5 | 224,815,751.88 |
| 营业总成本 | 149,648,560.25 | 79,589,898.46 | 365,095,549.48 | 250,688,000.98 |
| 其他经营收益 | | | | |
| 营业利润 | -13,148,850.29 | -6,683,017.35 | -51,177,347.51 | -12,386,818.03 |
| 利润总额 | -13,134,461.23 | -6,678,998.46 | -49,589,335.03 | -12,736,160.17 |
| 净利润 | -14,976,930.24 | -6,807,935.66 | -50,074,553.84 | -15,062,945.83 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | -14,976,930.24 | -6,807,935.66 | -50,074,553.84 | -15,062,945.83 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 358,208,210.29 | 365,527,033.61 | 378,867,840.94 | 431,229,589.38 |
| 非流动资产: | | | | |
| 非流动资产合计 | 507,935,288.64 | 510,028,692.13 | 510,599,659.42 | 514,359,709.82 |
| 资产总计 | 866,143,498.93 | 875,555,725.74 | 889,467,500.36 | 945,589,299.2 |
| 流动负债: | | | | |
| 流动负债合计 | 186,933,091.86 | 194,932,376.25 | 201,328,388.31 | 162,462,572.37 |
| 非流动负债: | | | | |
| 非流动负债合计 | 145,448,577.97 | 138,238,349.43 | 138,652,870.42 | 197,274,192.49 |
| 负债合计 | 332,381,669.83 | 333,170,725.68 | 339,981,258.73 | 359,736,764.86 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 532,643,657.32 | 540,799,296.02 | 547,612,826.7 | 583,425,514.95 |
| 股东权益合计 | 533,761,829.1 | 542,385,000.06 | 549,486,241.63 | 585,852,534.34 |
| 负债和股东权益合计 | 866,143,498.93 | 875,555,725.74 | 889,467,500.36 | 945,589,299.2 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 133,953,653.93 | 61,660,999.05 | 403,244,320.35 | 329,599,632.4 |
| 经营活动现金流出小计 | 156,146,600.65 | 85,501,919.62 | 374,287,098.32 | 296,467,904.51 |
| 经营活动产生的现金流量净额 | -22,192,946.72 | -23,840,920.57 | 28,957,222.03 | 33,131,727.89 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 70,875,871.5 | 2,629,918.62 | 314,429,920.88 | 168,481,998.69 |
| 投资活动现金流出小计 | 123,965,116.26 | 52,677,260.68 | 302,807,066.02 | 233,333,049.45 |
| 投资活动产生的现金流量净额 | -53,089,244.76 | -50,047,342.06 | 11,622,854.86 | -64,851,050.76 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 8,335,965.85 | - | 54,680,830.36 | 51,899,788.77 |
| 筹资活动现金流出小计 | 12,565,235.99 | 1,385,288.61 | 85,849,171.66 | 39,771,287.95 |
| 筹资活动产生的现金流量净额 | -4,229,270.14 | -1,385,288.61 | -31,168,341.3 | 12,128,500.82 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -79,511,461.62 | -75,273,551.24 | 9,411,735.59 | -19,590,822.05 |
| 期末现金及现金等价物余额 | 90,488,961.72 | 95,104,266.94 | 170,000,423.34 | 140,997,865.7 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -79,511,461.62 | - | 9,411,735.59 | - |